Mitotic kinesin inhibitors

Details Mitotic kinesin inhibitors Mitotic kinesin inhibitors

2006-06-13

2006-06-13

Balasubramanian, Venkataraman (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S266220, C514S212080, C514S227800, C514S230500, C544S287000, C544S060000, C544S105000, C540S485000, C540S492000

Reexamination Certificate

active

07060705

ABSTRACT:
The present invention relates to quinazolinone compounds that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention also related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.

REFERENCES:
patent: 3322756 (1967-05-01), Ruschig et al.
patent: 3984555 (1976-10-01), Amschler et al.
patent: 1 584 579 (1969-12-01), None
patent: WO 98 26664 (1998-06-01), None
patent: WO 01 30768 (2001-05-01), None
patent: WO 01 81346 (2001-11-01), None
patent: WO 01 98278 (2001-12-01), None
patent: WO 03 070701 (2003-08-01), None
Mayer et al., Science 286: 971-974, 1999.
Bergnes et al., Curr. Top. Med. Chem. 5(2), 127-145, 2005.
Sakowicz et al., Cancer Research 64, 3276-3280, 2004.
DeBonis et al., Molecular Cancer Therapeutics, 3(9), 1079-1090, 2004.
Wood et al., Current Opinion in Pharmcology 1, 370-377, 2001.
Cancer Research 64, pp. 3276-3280, May 1, 2004, by R. Sakowicz, et al.
J. Med Chem., vol. 42, pp. 3203-3209 (1999), by A. Kumar Debnath, et al.
J. Med. Chem, vol. 11, No. 2, pp. 392-395, (1968), by C.M. Gupta, et al.
J. Indian Chem. Soc., 68(3), pp. 142-143, 1991, by S. Saxena, et al.

Affiliated with

Also associated with

Rating

Mitotic kinesin inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Mitotic kinesin inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mitotic kinesin inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3643229